Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tykerb in advanced hepatocellular and biliary carcinomas
NCT00107536Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2005
- Primary completion
- May 2009
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in hepatocellular carcinoma (HCC), biliary tract carcinoma (BTC), sponsored by National Cancer Institute. Started Oct 2005; status: completed.
02
Drugs
lapatinib
03
Conditions
hepatocellular carcinoma (HCC)biliary tract carcinoma (BTC)
Beyond the preview
Go deeper on NCT00107536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107536.